Skip to content
Delayed ~15 min

XPOF XPONENTIAL FITNESS CLASS A

Permanent stock page ↗

Consumer Discretionary · Russell 2000

Next earnings: not announced yet

What 12 analyst firms say about XPONENTIAL FITNESS CLASS A: their latest ratings, price targets and how far the stock is from them. How it works

4.65 USD+0.23 (+5.20%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+22.3%to the avg target 5.69 USD+1.04 USD
Buy 1 · Hold 10 · Sell 0

11 rated views · 13 analyst/firm records · 12 firms

Latest report2 Nov 2026avg report date 16 Jul
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
  • Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD

Recent analyst activity · last 90 days

Our tracked history has 7 reports on XPOF from 6 analyst firms in the last 90 days (12 firms in the past year).

Comparing each firm's latest target with its previous one: 2 lowered it, 1 left it unchanged and 1 has its first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: Northland Capital lowered its target from $8.00 (set 20 May 2026) to $7.00 on 2 Nov 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
B Riley SecuritiesJeff Van SinderenHold10 Aug 20265.00 USD
BairdJonathan KompConflictConflicting reports · excluded7 Aug 20265.50 USD
GuggenheimJohn HeinbockelHold7 Aug 2026—
KeyBanc Capital MarketsNoah ZatzkinHold11 Sep 2026—
Lake Street Capital MarketsRyan R MeyersHold8 May 20266.00 USD
Northland Capital MarketsOwen RickertBuy2 Nov 20267.00 USD
Raymond JamesJoseph N AltobelloHold6 Aug 2026—
Roth CapitalGeorge KellyHold10 Aug 20265.00 USD
StifelChris O'CullHold21 Nov 20258.00 USD
UBSArpine KocharianHold16 Sep 20264.50 USD
UBSArpine KocharyanHold16 Sep 20264.50 USD
Weiss RatingsUnnamed analyst—16 Oct 2026—
Data feed RESEARCHResearch TeamHold7 Jul 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 03:26 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.